Gelatinase activity is induced in renal vascular lesions of rats with malignant hypertension
Authors:
Open Access
- 26 October 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 34347
Abstract
We previously reported a RNASeq analysis comparing kidney injury in malignant 2-kidney-1-clip hypertension versus the “benign” form of hypertension. RNAseq pointed to differential expression of many matrix metalloproteases (MMPs). We now investigated the regulation of MMP expression, immunohistochemistry and gelatinase activity in more detail. Mean blood pressure was elevated in benign hypertension (188 ± 10 mmHg) and even more pronounced in malign hypertension (236 ± 4 mmHg), compared to sham operated controls (128 ± 9mmHg). MMP2, 7, 12, 16 and 19 expression was significantly higher in malignant compared to non-malignant hypertension. The only exception was MMP9 mRNA which decreased by 0.2-fold. Gelatinase activity was detected in vascular lesions of malignant hypertension in kidneys exposed to high blood pressure. The number of gelatinase activity lesions correlated with MMP2 expression. There was no gelatinase activity in shams, or in left (post-stenotic) kidneys of hypertensive rats. MMP2 staining was detected at vascular lesions of malignant hypertensives. MMP9 staining was observed in tubules, interstitial cells, and intact vessels but absent from malignant vascular lesions. TIMP1 and 2 were detected in tubular cells. Thus, in malignant hypertension, most MMPs are upregulated. The gelatinases MMP2 and MMP9 exhibited a strikingly divergent regulation, with MMP2 localizing to malignant vascular lesions with gelatinase activity.Keywords
Funding Information
- Universitätsklinikum Erlangen
This publication has 25 references indexed in Scilit:
- Malignant Hypertension:A Systemic Cardiovascular DiseaseJACC, 2024
- TNFα induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1/JNK/ERK/NF-kB signaling pathwaysScientific Reports, 2023
- RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertensionJournal of Molecular Medicine, 2021
- Key metalloproteinase-mediated pathways in the kidneyNature Reviews Nephrology, 2021
- Malignant hypertension: does this still exist?Journal of Human Hypertension, 2019
- Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertensionAtherosclerosis, 2018
- Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertensionMatrix Biology, 2012
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive ratsAtherosclerosis, 2008
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseasesNature Reviews Drug Discovery, 2007
- RNA integrity and the effect on the real-time qRT-PCR performanceMolecular Aspects of Medicine, 2006